Company logo

GOCO - GoHealth, Inc.

NASDAQ -> Financial Services -> Insurance Brokers
Chicago, United States
Type: Equity

GOCO price evolution
GOCO
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Current assets
Cash $215.4 $76.16 $129.63 $84.36
Short term investments
Net receivables $1181.88 $1198.9 $1176.68 $1279.78
Inventory
Total current assets $468.15 $333.01 $391.76 $429
Long term investments
Property, plant & equipment $48.37 $52.97 $49.91 $47.73
Goodwill & intangible assets $524.13 $547.64 $571.15 $594.67
Total noncurrent assets $1533.53 $1565.05 $1571.2 $1639.86
Total investments
Total assets $2001.68 $1898.06 $1962.96 $2068.85
Current liabilities
Accounts payable $384.78 $366.93 $363.69 $418.41
Deferred revenue $114.18 $2.69 $1.14 $0.54
Short long term debt $14.65 $15.27 $11.52 $11.4
Total current liabilities $255.42 $141.89 $140.89 $217.07
Long term debt $699.06 $702.97 $680.86 $684.89
Total noncurrent liabilities $1057.02 $997.84 $962.11 $959.29
Total debt $713.71 $718.23 $692.38 $696.29
Total liabilities $1312.44 $1139.74 $1103 $1176.36
Shareholders' equity
Retained earnings -$295.69 -$265.62 -$221.8 -$208.32
Other shareholder equity -$0.17 -$0.23 -$0.1 -$0.06
Total shareholder equity $324.94 $346.46 $361.13 $353.1
(in millions $) 31 Dec 2021 31 Dec 2020 30 Dec 2019 30 Dec 2018
Current assets
Cash $84.36 $144.23 $12.28 $0.51
Short term investments
Net receivables $1279.78 $840.66 $125.54 $48.54
Inventory
Total current assets $429 $391.82 $143.77 $54.03
Long term investments
Property, plant & equipment $47.73 $17.35 $6.34 $11.78
Goodwill & intangible assets $594.67 $1075.28
Total noncurrent assets $1639.86 $1716.97 $1458.53
Total investments
Total assets $2068.85 $2108.8 $1602.3 $142.84
Current liabilities
Accounts payable $418.41 $269.81 $13.58 $10.53
Deferred revenue $0.54 $0.74 $15.22
Short long term debt $11.4 $4.17 $3 $4.86
Total current liabilities $217.07 $127.37 $113.06 $47.98
Long term debt $684.89 $396.4 $288.23 $0.2
Total noncurrent liabilities $959.29 $582.27 $629.09
Total debt $696.29 $400.57
Total liabilities $1176.36 $709.64 $742.15 $329.49
Shareholders' equity
Retained earnings -$208.32 -$18.8 -$189.1
Other shareholder equity -$0.06 $0.02 -$0.02 $0.01
Total shareholder equity $353.1 $380.42 $312.6 -$186.65
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Revenue
Total revenue $133.05 $158.65 $270.59 $449.6
Cost of revenue $48.04 $51.07 $67.92 $99.89
Gross Profit $85.01 $107.58 $202.67 $349.71
Operating activities
Research & development $11.06 $10.75 $12.76 $15.18
Selling, general & administrative $48.27 $82.82 $113.25 $224.42
Total operating expenses $144.15 $208.62 $227.98 $772.99
Operating income -$59.14 -$101.04 -$25.31 -$423.28
Income from continuing operations
EBIT -$14.38 -$31.09 -$1.61 -$145.36
Income tax expense $0.47 $0.12
Interest expense $15.63 $12.72 $11.4 $9.62
Net income
Net income -$30 -$43.82 -$13.48 -$155.09
Income (for common shares) -$30 -$43.82 -$13.48 -$155.09
(in millions $) 31 Dec 2021 31 Dec 2020 30 Dec 2019 30 Dec 2018
Revenue
Total revenue $1062.41 $877.35 $539.5 $226.21
Cost of revenue $239.34 $199.2 $169.55 $79.58
Gross Profit $823.08 $678.15 $369.95 $146.62
Operating activities
Research & development $48.43 $59.35 $46.32 $16.2
Selling, general & administrative $463.32 $404.09 $248.98 $101.66
Total operating expenses $1312.53 $722.99 $493.07 $197.44
Operating income -$489.45 -$44.85 $46.44 $28.76
Income from continuing operations
EBIT -$155.88 -$11.26 $46.44 $28.76
Income tax expense -$0.02 $0.04 -$0.02 $0.05
Interest expense $33.51 $32.97 -$8.22 -$0.22
Net income
Net income -$189.36 -$44.27 -$41.07 $28.12
Income (for common shares) -$189.36 -$44.27 $15.99 $28.12
(in millions $) 30 Sep 2022 30 Jun 2022 31 Mar 2022 31 Dec 2021
Net income -$30 -$43.82 -$13.48 -$155.09
Operating activities
Depreciation $29.27 $27.86 $27.37 $35.37
Business acquisitions & disposals
Stock-based compensation $5.48 $12.14 $5.16 $7.2
Total cash flows from operations $95.53 -$48.11 $54.49 -$226.59
Investing activities
Capital expenditures -$2.44 -$3.66 -$6 -$0.53
Investments
Total cash flows from investing -$2.44 -$3.66 -$6 -$0.53
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings -$2.36 -$1.36 -$3.1 $229.74
Total cash flows from financing $46 -$1.36 -$3.1 $226.35
Effect of exchange rate $0.16 -$0.34 -$0.12 -$0.09
Change in cash and equivalents $139.25 -$53.47 $45.27 -$0.86
(in millions $) 31 Dec 2021 31 Dec 2020 30 Dec 2019 30 Dec 2018
Net income -$189.36 -$44.27 -$41.07 $28.12
Operating activities
Depreciation $112.54 $98.55 $8.64 $1.55
Business acquisitions & disposals
Stock-based compensation $27.3 $216.23
Total cash flows from operations -$299.01 -$114.22 -$0 $5.44
Investing activities
Capital expenditures -$19.8 -$14.52 -$8.02 -$6.17
Investments
Total cash flows from investing -$19.8 -$14.52 -$815.61 -$6.17
Financing activities
Dividends paid -$0.4 -$0.4
Sale and purchase of stock $862.41
Net borrowings $259.09 $103.14 $295.45 $0.14
Total cash flows from financing $259.09 $260.66 $827.43 $0.06
Effect of exchange rate -$0.15 $0.04 -$0.05 -$0
Change in cash and equivalents -$59.87 $131.96 $11.77 -$0.67
Fundamentals
Market cap N/A
Enterprise value N/A
Shares outstanding N/A
Revenue $1.01B
EBITDA -$72.59M
EBIT -$192.44M
Net Income -$242.40M
Revenue Q/Q -37.16%
Revenue Y/Y -4.42%
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA -12.22%
ROE -69.98%
Debt/Equity 3.33
Net debt/EBITDA -15.11
Current ratio 1.83
Quick ratio 1.83